Dual Inhibitor of MurD and MurE Ligases from Escherichia coli and Staphylococcus aureus.
Tomasic, T., Sink, R., Zidar, N., Fic, A., Contreras-Martel, C., Dessen, A., Patin, D., Blanot, D., Muller-Premru, M., Gobec, S., Zega, A., Kikelj, D., Masic, L.P.(2012) ACS Med Chem Lett 3: 626-630
- PubMed: 24900523 
- DOI: https://doi.org/10.1021/ml300047h
- Primary Citation of Related Structures:  
2Y1O - PubMed Abstract: 
MurD and MurE ligases, consecutive enzymes participating in the intracellular steps of bacterial peptidoglycan biosynthesis, are important targets for antibacterial drug discovery. We have designed, synthesized, and evaluated the first d-glutamic acid-containing dual inhibitor of MurD and MurE ligases from Escherichia coli and Staphylococcus aureus (IC50 values between 6.4 and 180 μM) possessing antibacterial activity against Gram-positive S. aureus and its methicillin-resistant strain (MRSA) with minimal inhibitory concentration (MIC) values of 8 μg/mL. The inhibitor was also found to be noncytotoxic for human HepG2 cells at concentrations below 200 μM.
Organizational Affiliation: 
Faculty of Pharmacy, University of Ljubljana , Aškerčeva 7, 1000 Ljubljana, Slovenia.